Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_CHD,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.24 [1.19-1.29],1.95133748171876e-26,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LPA,Apolipoprotein(a),Inverse variance weighted,38,1.13 [1.1-1.17],3.29433312708885e-17,cis
Chapter IX Diseases of the circulatory system,I9_CHD,APOE,Apolipoprotein E,Inverse variance weighted,23,0.9 [0.87-0.94],5.93680301935517e-08,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FURIN,Furin,Wald ratio,1,1.26 [1.15-1.38],7.91222740094828e-07,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.4 [1.17-1.67],0.000261751575241305,cis
Chapter IX Diseases of the circulatory system,I9_CHD,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.86 [0.79-0.93],0.000450457825986463,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.22 [1.09-1.36],0.000714954272783188,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.96 [0.93-0.98],0.0007952542118894,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NRP1,Neuropilin-1,Inverse variance weighted,12,0.93 [0.89-0.97],0.000842768945327446,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.17 [1.06-1.29],0.00131551577152291,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.96 [0.94-0.99],0.00339793125745768,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.11 [1.04-1.2],0.00357922911943373,cis
Chapter IX Diseases of the circulatory system,I9_CHD,POMC,Pro-opiomelanocortin,Inverse variance weighted,2,0.74 [0.61-0.91],0.00399671034601348,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.93 [0.88-0.98],0.00455323823215107,cis
Chapter IX Diseases of the circulatory system,I9_CHD,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.06 [1.02-1.1],0.0050773746697295,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.09 [1.03-1.16],0.00549809005422081,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,1.05 [1.01-1.08],0.00601957980158589,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,16,0.95 [0.91-0.99],0.00863895597210242,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.95 [0.91-0.99],0.00894348706650213,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.9 [0.83-0.97],0.00899737880409113,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.87 [0.78-0.97],0.00984846264737,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.95 [0.92-0.99],0.0100681390567655,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CALCA,Calcitonin,Inverse variance weighted,5,0.84 [0.74-0.96],0.0101562288688143,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.84 [0.73-0.96],0.0101811859391026,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.1 [1.02-1.19],0.0115420606962112,cis
Chapter IX Diseases of the circulatory system,I9_CHD,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.06 [1.01-1.11],0.0115923420848739,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.81 [0.69-0.96],0.0124789462885031,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.9 [0.82-0.98],0.0138054662362153,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.03 [1.01-1.06],0.015391580808616,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.11 [1.02-1.21],0.0158635409489896,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NFASC,Neurofascin,Inverse variance weighted,15,0.95 [0.91-0.99],0.0161886339483366,cis
Chapter IX Diseases of the circulatory system,I9_CHD,F7,Coagulation factor VII,Inverse variance weighted,21,1.05 [1.01-1.09],0.0167724561356416,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.18 [1.03-1.36],0.0168791515929917,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.05 [1.01-1.09],0.0190071629094914,cis
Chapter IX Diseases of the circulatory system,I9_CHD,OGN,Mimecan,Inverse variance weighted,30,0.96 [0.92-0.99],0.0203993145265631,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.07 [1.01-1.13],0.0225164481248705,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.89 [0.8-0.98],0.0232665261051273,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.95 [0.91-0.99],0.0258622066409248,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.94 [0.89-0.99],0.026162637539259,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CLEC3B,Tetranectin,Inverse variance weighted,7,0.92 [0.86-0.99],0.0262704240767231,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.98 [0.96-1],0.0307891400116797,cis
Chapter IX Diseases of the circulatory system,I9_CHD,REN,Renin,Inverse variance weighted,4,1.08 [1.01-1.17],0.0323053078617988,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MVK,Mevalonate kinase,Inverse variance weighted,2,0.83 [0.7-0.98],0.0325083517635376,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.04 [1-1.08],0.0348118966306438,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.77 [0.6-0.99],0.0402939870635136,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.92 [0.85-1],0.0451783296082331,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.03 [1-1.06],0.0452414109453972,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.05 [1-1.09],0.0464778773919017,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.97 [0.94-1],0.0468017220477931,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.95 [0.9-1],0.0472468681297052,cis
Chapter IX Diseases of the circulatory system,I9_CHD,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.02 [1-1.05],0.0502422631538936,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1.02 [1-1.03],0.0514578235008362,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,0.92 [0.85-1],0.0550408877550378,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.91 [0.83-1],0.0584768322725015,cis
Chapter IX Diseases of the circulatory system,I9_CHD,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.05 [1-1.11],0.058654326448908,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.02 [1-1.04],0.0597470761076012,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.07 [1-1.14],0.0598462519461141,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.97 [0.95-1],0.0601295847325489,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.96 [0.91-1],0.0602137896404153,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FABP6,Gastrotropin,Wald ratio,1,0.89 [0.79-1.01],0.061131974612719,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.04 [1-1.08],0.0615665396371327,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.09 [1-1.18],0.0626255957684564,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.11 [0.99-1.23],0.0681923142225692,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.95 [0.9-1],0.0731826335322473,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.03 [1-1.07],0.0740799082138144,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.02 [1-1.04],0.0774939719815614,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CDH2,Cadherin-2,Inverse variance weighted,3,1.16 [0.98-1.37],0.0782251308237108,cis
Chapter IX Diseases of the circulatory system,I9_CHD,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.88 [0.76-1.02],0.0829279933216073,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LAYN,Layilin,Inverse variance weighted,20,0.95 [0.9-1.01],0.0834054390221805,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MMP7,Matrilysin,Inverse variance weighted,13,1.04 [0.99-1.08],0.0839038504703144,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.08 [0.99-1.19],0.0843420957914907,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LDLR,Low-density lipoprotein receptor,Wald ratio,1,1.81 [0.92-3.55],0.0856405496476704,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.86 [0.73-1.02],0.0896449138736657,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RSPO3,R-spondin-3,Inverse variance weighted,6,1.08 [0.99-1.19],0.0917842699859795,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,12,1.03 [0.99-1.07],0.0959929512790677,cis
Chapter IX Diseases of the circulatory system,I9_CHD,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,0.96 [0.91-1.01],0.0985330566764034,cis
Chapter IX Diseases of the circulatory system,I9_CHD,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.87 [0.73-1.03],0.105148810182966,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.83 [0.66-1.04],0.107518888090697,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.98 [0.96-1],0.109002758682009,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NRP2,Neuropilin-2,Inverse variance weighted,11,1.05 [0.99-1.11],0.112639871169541,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CTSL,Cathepsin L1,Wald ratio,1,0.76 [0.53-1.07],0.112973601596003,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.92 [0.84-1.02],0.115475413219232,cis
Chapter IX Diseases of the circulatory system,I9_CHD,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.06 [0.99-1.14],0.115954152905509,cis
Chapter IX Diseases of the circulatory system,I9_CHD,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.82 [0.63-1.05],0.117091614773518,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.34 [0.93-1.95],0.118030552172366,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.03 [0.99-1.07],0.119409894887873,cis
Chapter IX Diseases of the circulatory system,I9_CHD,DSC2,Desmocollin-2,Inverse variance weighted,9,0.96 [0.9-1.01],0.120377091010537,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CST3,Cystatin-C,Inverse variance weighted,10,1.05 [0.99-1.11],0.122902904996216,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GUCA2A,Guanylin,Inverse variance weighted,9,1.06 [0.98-1.13],0.123961179823704,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.24 [0.94-1.63],0.125070167716654,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.41 [0.91-2.18],0.127499626817236,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.05 [0.99-1.13],0.12778767031474,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KLK11,Kallikrein-11,Inverse variance weighted,6,1.04 [0.99-1.08],0.128427645547546,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.98 [0.96-1.01],0.128619313149024,cis
Chapter IX Diseases of the circulatory system,I9_CHD,AREG,Amphiregulin,Inverse variance weighted,3,0.92 [0.83-1.02],0.128936662210602,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.08 [0.98-1.19],0.129713149866597,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.04 [0.99-1.08],0.13138986847225,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CDH1,Cadherin-1,Wald ratio,1,0.77 [0.54-1.08],0.132042414242212,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.05 [0.98-1.12],0.135781244342996,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.96 [0.9-1.01],0.137445423152277,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SPP1,Osteopontin,Inverse variance weighted,8,1.1 [0.97-1.24],0.144289140048448,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD302,CD302 antigen,Inverse variance weighted,9,0.95 [0.89-1.02],0.146236313803311,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SPON1,Spondin-1,Inverse variance weighted,21,1.03 [0.99-1.07],0.146254571844174,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NECTIN4,Nectin-4,Inverse variance weighted,7,1.04 [0.99-1.09],0.149872704470863,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.05 [0.98-1.13],0.150686319154334,cis
Chapter IX Diseases of the circulatory system,I9_CHD,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.03 [0.99-1.07],0.151363967457606,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.12 [0.96-1.3],0.152149540799731,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.07 [0.97-1.18],0.153228539701299,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.04 [0.99-1.09],0.153611875097004,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.92 [0.82-1.03],0.153719003912324,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RBP2,Retinol-binding protein 2,Wald ratio,1,1.21 [0.93-1.58],0.15555931991312,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.98 [0.95-1.01],0.157576717056915,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KLK14,Kallikrein-14,Inverse variance weighted,15,1.03 [0.99-1.06],0.158723543586598,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,0.99 [0.97-1.01],0.169205597218566,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.05 [0.98-1.12],0.169513533745053,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1.02 [0.99-1.05],0.171160014696386,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,0.98 [0.96-1.01],0.173659686090674,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ANXA10,Annexin A10,Wald ratio,1,0.8 [0.59-1.1],0.174859056556264,cis
Chapter IX Diseases of the circulatory system,I9_CHD,UMOD,Uromodulin,Inverse variance weighted,29,1.01 [0.99-1.03],0.177253255050603,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PLAT,Tissue-type plasminogen activator,Wald ratio,1,0.81 [0.59-1.1],0.177448407339983,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.37 [0.86-2.2],0.189062770470811,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.91 [0.8-1.05],0.189958646255336,cis
Chapter IX Diseases of the circulatory system,I9_CHD,THPO,Thrombopoietin,Inverse variance weighted,3,1.14 [0.94-1.38],0.192727135175231,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PRSS2,Trypsin-2,Inverse variance weighted,3,0.93 [0.84-1.04],0.194033233842956,cis
Chapter IX Diseases of the circulatory system,I9_CHD,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.05 [0.98-1.13],0.195807613070754,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.17 [0.92-1.48],0.198170525026805,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,0.93 [0.84-1.04],0.198943953810167,cis
Chapter IX Diseases of the circulatory system,I9_CHD,APOD,Apolipoprotein D,Inverse variance weighted,7,0.97 [0.92-1.02],0.199694359833919,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EPO,Erythropoietin,Inverse variance weighted,5,0.89 [0.74-1.07],0.204123107184055,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CPM,Carboxypeptidase M,Inverse variance weighted,4,0.94 [0.85-1.04],0.207827019263713,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.19 [0.91-1.57],0.208113119840603,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EDN1,Endothelin-1,Inverse variance weighted,3,1.05 [0.97-1.12],0.210606122666808,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.97 [0.92-1.02],0.210742994775999,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD83,CD83 antigen,Inverse variance weighted,5,1.07 [0.96-1.19],0.212146799787975,cis
Chapter IX Diseases of the circulatory system,I9_CHD,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.08 [0.96-1.22],0.212525297612839,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NPPC,C-type natriuretic peptide,Wald ratio,1,0.78 [0.53-1.15],0.212637807529571,cis
Chapter IX Diseases of the circulatory system,I9_CHD,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.97 [0.94-1.02],0.214869388206509,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,34,0.99 [0.97-1.01],0.215934737496925,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GAL,Galanin peptides,Inverse variance weighted,3,0.83 [0.62-1.12],0.221197315144033,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KLK4,Kallikrein-4,Inverse variance weighted,17,1.02 [0.99-1.06],0.226320662991661,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,0.87 [0.69-1.09],0.226457464492449,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.19 [0.9-1.56],0.226463391261178,cis
Chapter IX Diseases of the circulatory system,I9_CHD,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.05 [0.97-1.14],0.227395752353214,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CALB2,Calretinin,Wald ratio,1,0.85 [0.66-1.11],0.229996123361272,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.95 [0.87-1.04],0.235187094472226,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.97 [0.92-1.02],0.23539637911709,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.02 [0.99-1.05],0.235658695735037,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1.01 [0.99-1.03],0.236250797219314,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.97 [0.92-1.02],0.236493918512121,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CREG1,Protein CREG1,Inverse variance weighted,3,0.95 [0.87-1.04],0.241238068051782,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.06 [0.96-1.16],0.241458733507633,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.8 [0.55-1.16],0.243019935176773,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,0.98 [0.95-1.01],0.244787041951588,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.91 [0.77-1.07],0.248312319189669,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.79 [0.53-1.18],0.249691282047714,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SELE,E-selectin,Inverse variance weighted,4,0.92 [0.79-1.06],0.252157092872108,cis
Chapter IX Diseases of the circulatory system,I9_CHD,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,1.39 [0.79-2.44],0.254160761377891,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.03 [0.98-1.09],0.254196048156778,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.97 [0.92-1.02],0.25586320820578,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PI3,Elafin,Inverse variance weighted,10,1.03 [0.98-1.09],0.256992048493287,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SCG3,Secretogranin-3,Inverse variance weighted,32,1.02 [0.99-1.05],0.261368254981758,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SOST,Sclerostin,Wald ratio,1,1.18 [0.88-1.59],0.264552142105963,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.12 [0.92-1.35],0.267118661239104,cis
Chapter IX Diseases of the circulatory system,I9_CHD,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.14 [0.9-1.45],0.269587254984941,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,1.11 [0.92-1.33],0.272546672246213,cis
Chapter IX Diseases of the circulatory system,I9_CHD,BSG,Basigin,Wald ratio,1,0.94 [0.84-1.05],0.276332325644769,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.04 [0.97-1.11],0.276990828583847,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CSTB,Cystatin-B,Inverse variance weighted,28,1.02 [0.99-1.05],0.278066531984521,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.05 [0.96-1.13],0.283289468700699,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.99-1.04],0.284299501349855,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.03 [0.98-1.09],0.285285701247027,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.94 [0.84-1.05],0.287837163545606,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.02 [0.99-1.05],0.293243584542741,cis
Chapter IX Diseases of the circulatory system,I9_CHD,INHBC,Inhibin beta C chain,Inverse variance weighted,29,1.02 [0.99-1.04],0.293502639440313,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CTSS,Cathepsin S,Inverse variance weighted,23,1.02 [0.98-1.06],0.294699858021622,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.02 [0.99-1.05],0.29693641109509,cis
Chapter IX Diseases of the circulatory system,I9_CHD,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.07 [0.94-1.2],0.297005222789844,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.93 [0.81-1.06],0.298470251805057,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ACAN,Aggrecan core protein,Inverse variance weighted,3,0.92 [0.79-1.07],0.300477403899785,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCN1,CCN family member 1,Inverse variance weighted,2,0.93 [0.8-1.07],0.301437667028633,cis
Chapter IX Diseases of the circulatory system,I9_CHD,C7,Complement component C7,Inverse variance weighted,38,0.99 [0.97-1.01],0.302248062256418,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CFH,Complement factor H,Inverse variance weighted,19,0.98 [0.93-1.02],0.307326541475318,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.98 [0.94-1.02],0.311542770379992,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.97 [0.91-1.03],0.312350790525947,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.02 [0.98-1.07],0.314704005036398,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.06 [0.95-1.18],0.315892621311188,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.84 [0.6-1.18],0.316578472840548,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.08 [0.93-1.25],0.3219907752672,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,0.99 [0.96-1.01],0.332166605502511,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.91 [0.76-1.1],0.337367971959078,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IFNL1,Interferon lambda-1,Wald ratio,1,1.19 [0.83-1.73],0.343305997420503,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.81 [0.53-1.24],0.343581657822609,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.95 [0.86-1.06],0.345141758367973,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PGA4,Pepsin A-4,Inverse variance weighted,2,1.17 [0.84-1.62],0.347922268931816,cis
Chapter IX Diseases of the circulatory system,I9_CHD,AGRN,Agrin,Inverse variance weighted,17,0.98 [0.93-1.03],0.352615693096611,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.96 [0.89-1.04],0.353430075635443,cis
Chapter IX Diseases of the circulatory system,I9_CHD,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,17,0.98 [0.93-1.03],0.363118929623895,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MDK,Midkine,Inverse variance weighted,4,1.08 [0.92-1.26],0.363673116196182,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.02 [0.98-1.05],0.364065056974193,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GHR,Growth hormone receptor,Inverse variance weighted,38,0.99 [0.97-1.01],0.367816218926501,cis
Chapter IX Diseases of the circulatory system,I9_CHD,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.14 [0.86-1.52],0.368805356579502,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.02 [0.98-1.07],0.370734875225466,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.06 [0.94-1.19],0.37348744612299,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,0.81 [0.51-1.29],0.377726235926075,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.04 [0.95-1.14],0.381004387881229,cis
Chapter IX Diseases of the circulatory system,I9_CHD,APOL1,Apolipoprotein L1,Inverse variance weighted,3,1.04 [0.96-1.13],0.383822192230067,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.01 [0.99-1.04],0.38437938519976,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.01 [0.98-1.04],0.385845865073834,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.01 [0.98-1.05],0.38865344018234,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,21,0.99 [0.96-1.02],0.395828557753008,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.97 [0.9-1.04],0.398132943414863,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.95 [0.86-1.06],0.398388217299353,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.02 [0.97-1.07],0.399974862775648,cis
Chapter IX Diseases of the circulatory system,I9_CHD,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.03 [0.96-1.12],0.400495509372271,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.13 [0.85-1.52],0.401317442367734,cis
Chapter IX Diseases of the circulatory system,I9_CHD,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1.01 [0.99-1.04],0.401914034745109,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CFD,Complement factor D,Inverse variance weighted,11,0.97 [0.91-1.04],0.402116927528259,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.95 [0.85-1.07],0.405441806283326,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,32,1.01 [0.98-1.05],0.413196026649947,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,1.02 [0.97-1.08],0.414370572600779,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.9 [0.7-1.16],0.416610572553601,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.02 [0.97-1.08],0.417071832335131,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.03 [0.96-1.1],0.418556242005653,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,0.96 [0.88-1.05],0.421348471003622,cis
Chapter IX Diseases of the circulatory system,I9_CHD,AMBP,Protein AMBP,Inverse variance weighted,3,0.94 [0.82-1.09],0.42790279311156,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.04 [0.94-1.15],0.431271765658582,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CHGB,Secretogranin-1,Inverse variance weighted,27,0.99 [0.96-1.02],0.431842875632245,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.99 [0.97-1.01],0.432940856432706,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.02 [0.97-1.06],0.440668901927819,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.06 [0.92-1.22],0.444190808796703,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.89 [0.67-1.19],0.44419967424076,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MUC13,Mucin-13,Inverse variance weighted,9,0.98 [0.92-1.04],0.444446925335556,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.99 [0.95-1.02],0.444504141829915,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HMOX1,Heme oxygenase 1,Wald ratio,1,1.1 [0.86-1.4],0.44904987810253,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.03 [0.95-1.11],0.452171596509814,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LGALS9,Galectin-9,Inverse variance weighted,26,0.99 [0.95-1.02],0.45234394271531,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MFGE8,Lactadherin,Inverse variance weighted,11,1.03 [0.96-1.09],0.454779944026743,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.98 [0.94-1.03],0.456928277178454,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.96 [0.87-1.06],0.458388172968731,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MB,Myoglobin,Wald ratio,1,1.17 [0.77-1.8],0.46055458106308,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.08 [0.88-1.33],0.460648180557978,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.03 [0.95-1.11],0.461712864594808,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.02 [0.96-1.09],0.461944347403085,cis
Chapter IX Diseases of the circulatory system,I9_CHD,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.06 [0.91-1.23],0.464862872621855,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.01 [0.98-1.05],0.468065608261176,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.02 [0.97-1.08],0.469893182080919,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ITGA11,Integrin alpha-11,Inverse variance weighted,8,0.97 [0.9-1.05],0.472432376520049,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.01 [0.98-1.04],0.48186828354049,cis
Chapter IX Diseases of the circulatory system,I9_CHD,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.14 [0.79-1.65],0.482654837011944,cis
Chapter IX Diseases of the circulatory system,I9_CHD,XCL1,Lymphotactin,Inverse variance weighted,31,1.01 [0.98-1.04],0.485145079173672,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.02 [0.96-1.1],0.491117677818271,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.01 [0.98-1.05],0.496157266222684,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,12,1.02 [0.97-1.07],0.497913064084708,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.99 [0.95-1.02],0.499472401691799,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.98 [0.91-1.05],0.501668281548522,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.98 [0.93-1.04],0.507981352941888,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.01 [0.99-1.03],0.50992420704322,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.99 [0.94-1.03],0.510416273882662,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.01 [0.98-1.04],0.512575807555602,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.01 [0.98-1.05],0.513518192973888,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.06 [0.88-1.29],0.514091060866751,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.99 [0.95-1.02],0.517076972845239,cis
Chapter IX Diseases of the circulatory system,I9_CHD,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.88 [0.59-1.3],0.517983278964851,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PLXNB2,Plexin-B2,Inverse variance weighted,27,0.99 [0.98-1.01],0.519227379454088,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.98 [0.93-1.03],0.524114148066856,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CTSD,Cathepsin D,Inverse variance weighted,17,0.99 [0.94-1.03],0.525870654046888,cis
Chapter IX Diseases of the circulatory system,I9_CHD,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.99 [0.96-1.02],0.52780476651948,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,1.01 [0.98-1.04],0.537064515205269,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.98 [0.92-1.05],0.537621325789829,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PTN,Pleiotrophin,Inverse variance weighted,4,1.06 [0.88-1.29],0.54075741933221,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PRSS8,Prostasin,Inverse variance weighted,5,0.96 [0.84-1.09],0.544942500478965,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.02 [0.96-1.08],0.55268496373096,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.03 [0.94-1.12],0.5533862687786,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1.03 [0.93-1.15],0.556656872856097,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.03 [0.94-1.13],0.559330118608515,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.97 [0.89-1.06],0.560297483353651,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.14 [0.74-1.76],0.561335912803022,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GRN,Progranulin,Inverse variance weighted,7,0.98 [0.93-1.04],0.561744799309554,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.96 [0.82-1.11],0.563473578045857,cis
Chapter IX Diseases of the circulatory system,I9_CHD,OCLN,Occludin,Inverse variance weighted,2,1.03 [0.92-1.17],0.582243874011543,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.97 [0.86-1.09],0.584815197148333,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.03 [0.92-1.15],0.588817821353483,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.02 [0.95-1.1],0.593882559545915,cis
Chapter IX Diseases of the circulatory system,I9_CHD,APCS,Serum amyloid P-component,Inverse variance weighted,4,0.97 [0.85-1.1],0.595528335557215,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.96 [0.83-1.12],0.596811024064064,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HJV,Hemojuvelin,Wald ratio,1,1.02 [0.94-1.12],0.598508028452649,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.95 [0.79-1.14],0.607311845044522,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,0.94 [0.74-1.19],0.611346867298434,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.09 [0.79-1.5],0.612348760334156,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.02 [0.94-1.1],0.616119631269923,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.03 [0.91-1.17],0.621874416979754,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.99 [0.94-1.04],0.622050824236418,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.98 [0.91-1.06],0.622178717883167,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCN5,CCN family member 5,Inverse variance weighted,8,1.03 [0.91-1.17],0.628338783137096,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.04 [0.87-1.25],0.629594798261307,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.02 [0.95-1.09],0.630010286322097,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.98 [0.92-1.05],0.634360163420613,cis
Chapter IX Diseases of the circulatory system,I9_CHD,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.02 [0.95-1.09],0.635063370356924,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PALM2,Paralemmin-2,Inverse variance weighted,8,1.02 [0.95-1.08],0.642859045227941,cis
Chapter IX Diseases of the circulatory system,I9_CHD,COLEC12,Collectin-12,Inverse variance weighted,11,1.02 [0.95-1.09],0.646353067130542,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.91 [0.6-1.38],0.653672061672201,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LGALS3,Galectin-3,Inverse variance weighted,25,0.99 [0.96-1.03],0.656772484139114,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.01 [0.96-1.06],0.660229314851041,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.97 [0.85-1.1],0.661701039669623,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.99 [0.96-1.03],0.668612250602371,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,1.06 [0.8-1.42],0.669227897458117,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CNTN5,Contactin-5,Inverse variance weighted,28,0.99 [0.97-1.02],0.675762040556883,cis
Chapter IX Diseases of the circulatory system,I9_CHD,RETN,Resistin,Inverse variance weighted,9,0.99 [0.96-1.03],0.676752752023047,cis
Chapter IX Diseases of the circulatory system,I9_CHD,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.02 [0.95-1.09],0.6776857287271,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.09 [0.73-1.62],0.680382275111755,cis
Chapter IX Diseases of the circulatory system,I9_CHD,S100P,Protein S100-P,Inverse variance weighted,2,0.92 [0.6-1.4],0.682618969389046,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CFI,Complement factor I,Inverse variance weighted,6,0.98 [0.87-1.1],0.685543929794214,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MSLN,Mesothelin,Inverse variance weighted,25,1.01 [0.97-1.04],0.691246995212878,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LGALS4,Galectin-4,Inverse variance weighted,4,0.98 [0.89-1.08],0.697007618513826,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.94 [0.67-1.31],0.700616396059807,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.02 [0.92-1.13],0.700933860901307,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.95 [0.73-1.24],0.711738250778454,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.02 [0.92-1.13],0.714300918343368,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.02 [0.92-1.13],0.718530481343341,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,0.95 [0.73-1.25],0.720403717199492,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LMNB2,Lamin-B2,Wald ratio,1,0.93 [0.63-1.38],0.722507081237391,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.01 [0.96-1.06],0.723593254355406,cis
Chapter IX Diseases of the circulatory system,I9_CHD,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.08 [0.69-1.71],0.728610470916027,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SDC1,Syndecan-1,Inverse variance weighted,2,1.02 [0.9-1.16],0.732558757417053,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD27,CD27 antigen,Inverse variance weighted,9,0.99 [0.94-1.04],0.733420612128966,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,21,1 [0.97-1.02],0.734915997148329,cis
Chapter IX Diseases of the circulatory system,I9_CHD,AGRP,Agouti-related protein,Inverse variance weighted,3,1.05 [0.77-1.44],0.739497654242177,cis
Chapter IX Diseases of the circulatory system,I9_CHD,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,0.98 [0.84-1.13],0.740589262483917,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CHGA,Chromogranin-A,Inverse variance weighted,3,0.98 [0.84-1.13],0.741419683894217,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.01 [0.97-1.04],0.743075469943519,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NECTIN2,Nectin-2,Inverse variance weighted,5,0.98 [0.87-1.11],0.748623726894666,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.02 [0.89-1.18],0.748746053720861,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PSAP,Prosaposin,Inverse variance weighted,5,1.01 [0.94-1.09],0.753224896142628,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,0.99 [0.94-1.05],0.753904541416238,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KLKB1,Plasma kallikrein,Inverse variance weighted,15,1.01 [0.97-1.04],0.754512268364103,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.01 [0.95-1.07],0.760147456852882,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1 [0.97-1.04],0.761715827481729,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,0.99 [0.9-1.08],0.765230526231759,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1 [0.97-1.04],0.765953977872129,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.98 [0.84-1.14],0.767099183554959,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.01 [0.94-1.08],0.770445738607975,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.99 [0.94-1.04],0.776104620076097,cis
Chapter IX Diseases of the circulatory system,I9_CHD,VWC2,Brorin,Inverse variance weighted,22,0.99 [0.95-1.04],0.777465238373332,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.99 [0.95-1.04],0.780980234568599,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.99 [0.92-1.06],0.783287069885888,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.99 [0.9-1.08],0.783613037768896,cis
Chapter IX Diseases of the circulatory system,I9_CHD,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.99 [0.92-1.07],0.785658774593788,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.99 [0.95-1.04],0.786571150920147,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1 [0.97-1.03],0.788755666685636,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KLK8,Kallikrein-8,Inverse variance weighted,12,1.01 [0.96-1.06],0.794111936301338,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.99 [0.9-1.08],0.80060293546801,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.99 [0.92-1.07],0.800876316637384,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.01 [0.93-1.09],0.802068524755566,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCN3,CCN family member 3,Inverse variance weighted,19,0.99 [0.94-1.05],0.804468092672699,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MENT,Protein MENT,Inverse variance weighted,3,1.01 [0.96-1.05],0.804971318695101,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,16,0.99 [0.95-1.05],0.813241661671939,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CTSB,Cathepsin B,Inverse variance weighted,26,1 [0.97-1.03],0.816991704281527,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SPON2,Spondin-2,Inverse variance weighted,4,1.01 [0.93-1.09],0.819341726104536,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PGF,Placenta growth factor,Inverse variance weighted,2,0.92 [0.46-1.86],0.820105546016025,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.01 [0.95-1.07],0.829236701482167,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ANG,Angiogenin,Inverse variance weighted,19,1 [0.97-1.04],0.83010119415742,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.99 [0.94-1.05],0.830758147070242,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.99 [0.86-1.13],0.833991966136875,cis
Chapter IX Diseases of the circulatory system,I9_CHD,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.04 [0.73-1.47],0.841139962186459,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.01 [0.94-1.07],0.841178305071849,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.01 [0.95-1.06],0.845138231316705,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.02 [0.82-1.27],0.84923014499413,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1 [0.97-1.03],0.850072450005534,cis
Chapter IX Diseases of the circulatory system,I9_CHD,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.01 [0.94-1.07],0.851518296210705,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.98 [0.75-1.27],0.852758076743946,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.01 [0.92-1.11],0.857605686848856,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.01 [0.87-1.18],0.858116810162621,cis
Chapter IX Diseases of the circulatory system,I9_CHD,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1 [0.97-1.02],0.862627262202582,cis
Chapter IX Diseases of the circulatory system,I9_CHD,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.01 [0.93-1.09],0.863354100839165,cis
Chapter IX Diseases of the circulatory system,I9_CHD,PENK,Proenkephalin-A,Inverse variance weighted,19,0.99 [0.93-1.06],0.871441155996416,cis
Chapter IX Diseases of the circulatory system,I9_CHD,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,1.01 [0.86-1.19],0.874813914580177,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.99 [0.9-1.1],0.879781725586011,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1 [0.96-1.05],0.879861753763727,cis
Chapter IX Diseases of the circulatory system,I9_CHD,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.99 [0.85-1.15],0.888269618947096,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.01 [0.9-1.12],0.895808706817745,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.99 [0.89-1.11],0.896699405121829,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.99 [0.86-1.15],0.901357502637677,cis
Chapter IX Diseases of the circulatory system,I9_CHD,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.99 [0.88-1.12],0.902701436836424,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1 [0.93-1.08],0.907943629769543,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.01 [0.88-1.15],0.907967435617493,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1 [0.94-1.07],0.917683984932568,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1 [0.95-1.05],0.920692310612948,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LGALS1,Galectin-1,Inverse variance weighted,6,1 [0.96-1.05],0.923425308864529,cis
Chapter IX Diseases of the circulatory system,I9_CHD,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.01 [0.89-1.14],0.929049601376334,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1 [0.93-1.07],0.929210797000783,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.99 [0.75-1.31],0.934591841126341,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CTSZ,Cathepsin Z,Inverse variance weighted,3,1 [0.91-1.1],0.935449895753347,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1 [0.9-1.1],0.940316938490988,cis
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1 [0.91-1.09],0.94246528584661,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1 [0.9-1.12],0.95250374045246,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1 [0.96-1.04],0.953774716479961,cis
Chapter IX Diseases of the circulatory system,I9_CHD,KLB,Beta-klotho,Inverse variance weighted,32,1 [0.98-1.02],0.957501385517612,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1 [0.94-1.07],0.963141560876422,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CD209,CD209 antigen,Inverse variance weighted,15,1 [0.94-1.06],0.964481900844853,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1 [0.96-1.04],0.966331866201915,cis
Chapter IX Diseases of the circulatory system,I9_CHD,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1 [0.77-1.28],0.969283460273115,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.98-1.02],0.970589503193779,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,1 [0.95-1.05],0.972108248263978,cis
Chapter IX Diseases of the circulatory system,I9_CHD,F13B,Coagulation factor XIII B chain,Inverse variance weighted,33,1 [0.96-1.05],0.973186190499523,cis
Chapter IX Diseases of the circulatory system,I9_CHD,OSM,Oncostatin-M,Wald ratio,1,1 [0.8-1.27],0.973932546042492,cis
Chapter IX Diseases of the circulatory system,I9_CHD,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1 [0.94-1.07],0.976028022345446,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1 [0.87-1.15],0.977754886388256,cis
Chapter IX Diseases of the circulatory system,I9_CHD,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,1 [0.97-1.03],0.980145100351074,cis
Chapter IX Diseases of the circulatory system,I9_CHD,SCG2,Secretogranin-2,Wald ratio,1,1 [0.71-1.4],0.984218404263844,cis
Chapter IX Diseases of the circulatory system,I9_CHD,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1 [0.74-1.34],0.987268962711447,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1 [0.93-1.08],0.987372490147505,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1 [0.78-1.28],0.988419349490305,cis
Chapter IX Diseases of the circulatory system,I9_CHD,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,1 [0.95-1.05],0.988903042853269,cis
Chapter IX Diseases of the circulatory system,I9_CHD,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1 [0.88-1.13],0.997428072061984,cis
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,9.04 [6.43-12.71],7.05277185781944e-37,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,0.52 [0.45-0.59],3.04985278931749e-21,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GRN,Progranulin,Inverse variance weighted,46,1.08 [1.04-1.11],1.45852264289577e-05,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.55 [1.26-1.9],2.68991831316965e-05,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL6,Interleukin-6,Inverse variance weighted,6,0.87 [0.81-0.93],0.000107967780139684,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.2 [1.09-1.32],0.00017397806476288,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.22 [1.1-1.35],0.000253621692339872,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.27 [1.11-1.44],0.000281669540560051,trans
Chapter IX Diseases of the circulatory system,I9_CHD,AREG,Amphiregulin,Inverse variance weighted,5,1.28 [1.11-1.47],0.000905536413450878,trans
Chapter IX Diseases of the circulatory system,I9_CHD,POMC,Pro-opiomelanocortin,Inverse variance weighted,15,0.91 [0.85-0.97],0.00316602589675864,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.71 [0.56-0.89],0.00339659581781104,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.21 [1.06-1.37],0.00402735344964469,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.15 [1.04-1.27],0.00446458139296561,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.86 [0.78-0.96],0.00525745380564129,trans
Chapter IX Diseases of the circulatory system,I9_CHD,VWC2,Brorin,Inverse variance weighted,12,1.17 [1.05-1.3],0.00594823965353864,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.09 [1.02-1.16],0.00637881907396008,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,20,1.09 [1.02-1.16],0.00986572023822182,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.87 [0.78-0.97],0.0105331623412986,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.1 [1.02-1.19],0.0115420606962112,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.89 [0.81-0.97],0.0122282833631609,trans
Chapter IX Diseases of the circulatory system,I9_CHD,APOD,Apolipoprotein D,Inverse variance weighted,9,0.65 [0.46-0.91],0.0123399648180443,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.07 [1.01-1.13],0.0133349982612195,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.89 [0.82-0.98],0.0135831623155956,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.9 [0.83-0.98],0.0146601212762838,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.1 [1.02-1.19],0.0148621893809345,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.86 [0.77-0.97],0.0160581843896932,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.1 [1.01-1.2],0.0233172450139564,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.97 [0.94-1],0.0263097278455762,trans
Chapter IX Diseases of the circulatory system,I9_CHD,AGRP,Agouti-related protein,Inverse variance weighted,16,1.26 [1.03-1.54],0.0275122418406207,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.83 [0.7-0.98],0.0302097290054939,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.17 [1.02-1.36],0.030352679010738,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.83 [0.7-0.98],0.0327486221609776,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.89 [0.8-0.99],0.0330470687028658,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.84 [0.71-0.99],0.0345248101110589,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,0.86 [0.75-0.99],0.0378775712660615,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,1.53 [1.02-2.28],0.0382665198114061,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,0.86 [0.74-0.99],0.0389930818846264,trans
Chapter IX Diseases of the circulatory system,I9_CHD,APOL1,Apolipoprotein L1,Inverse variance weighted,46,1.04 [1-1.07],0.0415481753986022,trans
Chapter IX Diseases of the circulatory system,I9_CHD,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.29 [1.01-1.65],0.0432377352638338,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.92 [0.85-1],0.046631148064643,trans
Chapter IX Diseases of the circulatory system,I9_CHD,WNT9A,Protein Wnt-9a,Wald ratio,1,1.57 [1-2.46],0.0493673578172149,trans
Chapter IX Diseases of the circulatory system,I9_CHD,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.13 [1-1.27],0.0493792203697741,trans
Chapter IX Diseases of the circulatory system,I9_CHD,C7,Complement component C7,Inverse variance weighted,26,1.04 [1-1.07],0.0496362769218049,trans
Chapter IX Diseases of the circulatory system,I9_CHD,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.17 [1-1.38],0.0540026011309583,trans
Chapter IX Diseases of the circulatory system,I9_CHD,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.95 [0.9-1],0.0540694817340893,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCN1,CCN family member 1,Inverse variance weighted,6,1.71 [0.98-2.99],0.0575326576224383,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.3 [0.99-1.71],0.0583708320935075,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.95 [0.9-1],0.0586627580055864,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.09 [1-1.19],0.0598783845938274,trans
Chapter IX Diseases of the circulatory system,I9_CHD,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.21 [0.99-1.47],0.0643930431836882,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.45 [0.98-2.16],0.0647943911195656,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.05 [1-1.11],0.0649777288530815,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.75 [0.55-1.02],0.0704900421313057,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.17 [0.98-1.4],0.0760873386643557,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KLKB1,Plasma kallikrein,Inverse variance weighted,20,0.94 [0.88-1.01],0.0793641610719382,trans
Chapter IX Diseases of the circulatory system,I9_CHD,DSC2,Desmocollin-2,Inverse variance weighted,16,0.95 [0.9-1.01],0.0795675037209339,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MSLN,Mesothelin,Inverse variance weighted,11,1.14 [0.98-1.32],0.079611532054023,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NRP1,Neuropilin-1,Inverse variance weighted,14,0.91 [0.82-1.01],0.079753655690077,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ANG,Angiogenin,Inverse variance weighted,8,1.25 [0.97-1.6],0.0830549553859453,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CFP,Properdin,Inverse variance weighted,17,0.95 [0.9-1.01],0.0834326711123391,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.9 [0.81-1.01],0.083461568873655,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CFI,Complement factor I,Wald ratio,1,1.52 [0.95-2.46],0.0836853775262715,trans
Chapter IX Diseases of the circulatory system,I9_CHD,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.83 [0.67-1.03],0.0887057358956761,trans
Chapter IX Diseases of the circulatory system,I9_CHD,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.82 [0.66-1.03],0.0891790933118878,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.21 [0.97-1.51],0.091319280895081,trans
Chapter IX Diseases of the circulatory system,I9_CHD,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.23 [0.97-1.58],0.0931223224846293,trans
Chapter IX Diseases of the circulatory system,I9_CHD,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.94 [0.86-1.01],0.0935251101619736,trans
Chapter IX Diseases of the circulatory system,I9_CHD,OGN,Mimecan,Inverse variance weighted,37,0.97 [0.93-1.01],0.0954336004384713,trans
Chapter IX Diseases of the circulatory system,I9_CHD,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.38 [0.94-2.01],0.0974300220217188,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.93 [0.86-1.01],0.102345380476918,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.24 [0.96-1.61],0.102734064730096,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NECTIN4,Nectin-4,Inverse variance weighted,4,1.19 [0.96-1.47],0.106819296205867,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.87 [0.73-1.03],0.107539487004535,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.03 [0.99-1.08],0.115572558605182,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.26 [0.94-1.7],0.117520165816641,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.85 [0.68-1.04],0.118815279632819,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.1 [0.98-1.23],0.122502817257519,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LGALS9,Galectin-9,Inverse variance weighted,36,0.97 [0.94-1.01],0.124613847651581,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.13 [0.97-1.32],0.125404639827125,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.08 [0.98-1.18],0.125451380841469,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,0.95 [0.88-1.02],0.129229024053381,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.05 [0.99-1.11],0.131242535685124,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,14,0.94 [0.87-1.02],0.134553484643731,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.14 [0.96-1.36],0.138165197022193,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.8 [0.6-1.07],0.140292406342027,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.08 [0.97-1.2],0.140792335140559,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.2 [0.94-1.52],0.141095241966589,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,18,1.03 [0.99-1.08],0.144504065808904,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1.04 [0.99-1.1],0.148078092592686,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CTSL,Cathepsin L1,Inverse variance weighted,29,0.95 [0.88-1.02],0.149253547215732,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.96 [0.9-1.02],0.149550876876133,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.4 [0.88-2.25],0.158945506372559,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LAYN,Layilin,Inverse variance weighted,3,1.17 [0.94-1.46],0.163256831548565,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CSTB,Cystatin-B,Inverse variance weighted,23,1.02 [0.99-1.06],0.163649760879303,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.12 [0.95-1.32],0.16705536180905,trans
Chapter IX Diseases of the circulatory system,I9_CHD,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.94 [0.87-1.02],0.167711334883482,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL11,Eotaxin,Inverse variance weighted,11,1.04 [0.98-1.09],0.168281710229958,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.82 [0.61-1.09],0.168500618780352,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GHR,Growth hormone receptor,Inverse variance weighted,26,0.95 [0.88-1.02],0.170536446522976,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD302,CD302 antigen,Inverse variance weighted,11,0.93 [0.84-1.03],0.171017738042676,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MENT,Protein MENT,Inverse variance weighted,28,1.06 [0.98-1.14],0.175874804569516,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.95 [0.89-1.02],0.176529526613991,trans
Chapter IX Diseases of the circulatory system,I9_CHD,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.97 [0.93-1.01],0.177554348076015,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SPON2,Spondin-2,Inverse variance weighted,3,1.16 [0.93-1.44],0.178019243759673,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.04 [0.98-1.11],0.180697083190618,trans
Chapter IX Diseases of the circulatory system,I9_CHD,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.87 [0.71-1.07],0.18452703466882,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CDH1,Cadherin-1,Inverse variance weighted,16,0.97 [0.92-1.02],0.184994864202395,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CHGA,Chromogranin-A,Inverse variance weighted,5,0.92 [0.82-1.04],0.188428444011182,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.83 [0.63-1.09],0.189065974492049,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.03 [0.99-1.08],0.190902937123314,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.17 [0.92-1.48],0.191306917138463,trans
Chapter IX Diseases of the circulatory system,I9_CHD,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.1 [0.95-1.26],0.193329658124223,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.95 [0.88-1.03],0.204884915804238,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.76 [0.5-1.16],0.206151946192099,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.86 [0.68-1.09],0.207092470371557,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KLK8,Kallikrein-8,Inverse variance weighted,5,0.87 [0.7-1.08],0.207610948231445,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.07 [0.96-1.18],0.208001129373797,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.09 [0.95-1.23],0.209055747876755,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LGALS4,Galectin-4,Inverse variance weighted,15,0.97 [0.94-1.02],0.218773034478813,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,1.06 [0.97-1.15],0.219828165116402,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.01 [0.99-1.04],0.220429713352123,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MDK,Midkine,Inverse variance weighted,14,1.07 [0.96-1.19],0.221498148919216,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FABP6,Gastrotropin,Inverse variance weighted,4,0.86 [0.67-1.1],0.223313021227599,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KLK14,Kallikrein-14,Inverse variance weighted,15,1.06 [0.96-1.17],0.224268429186616,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.47 [0.79-2.72],0.224518200822055,trans
Chapter IX Diseases of the circulatory system,I9_CHD,REN,Renin,Inverse variance weighted,8,1.26 [0.87-1.84],0.224934118307337,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KLB,Beta-klotho,Inverse variance weighted,23,1.04 [0.97-1.12],0.22552543237436,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SCT,Secretin,Inverse variance weighted,5,1.1 [0.94-1.28],0.229829961824558,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.95 [0.88-1.03],0.229884009698469,trans
Chapter IX Diseases of the circulatory system,I9_CHD,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.16 [0.91-1.47],0.236043668107041,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,48,0.98 [0.94-1.02],0.240174954516088,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.81 [0.57-1.15],0.242440125158472,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.21 [0.88-1.66],0.246373087556002,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.02 [0.98-1.07],0.250451017580309,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.91 [0.77-1.07],0.251732791592461,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FURIN,Furin,Inverse variance weighted,3,0.9 [0.74-1.08],0.255010024531438,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.17 [0.89-1.54],0.255016239285797,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.09 [0.94-1.27],0.25598019658932,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MB,Myoglobin,Inverse variance weighted,9,0.93 [0.83-1.05],0.257785332798719,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.08 [0.95-1.22],0.259827268325477,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.09 [0.94-1.26],0.264017825790046,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GAST,Gastrin,Inverse variance weighted,9,0.94 [0.84-1.05],0.26490958384038,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,0.92 [0.8-1.06],0.265548204265512,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.04 [0.97-1.13],0.26596022980052,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.02 [0.99-1.06],0.268717304181776,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,7,0.96 [0.88-1.04],0.271170795396578,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CTSD,Cathepsin D,Inverse variance weighted,7,1.1 [0.93-1.31],0.272999367587638,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MFGE8,Lactadherin,Inverse variance weighted,15,1.11 [0.92-1.35],0.273830172726231,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.11 [0.92-1.33],0.274037371225087,trans
Chapter IX Diseases of the circulatory system,I9_CHD,S100P,Protein S100-P,Inverse variance weighted,4,0.92 [0.79-1.07],0.27971299939744,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.89 [0.71-1.1],0.281557525624202,trans
Chapter IX Diseases of the circulatory system,I9_CHD,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.94 [0.85-1.05],0.281845749525774,trans
Chapter IX Diseases of the circulatory system,I9_CHD,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.03 [0.97-1.09],0.282816200479344,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HJV,Hemojuvelin,Inverse variance weighted,2,1.22 [0.85-1.75],0.283996809589796,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,0.91 [0.77-1.08],0.28479805904962,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.88 [0.7-1.11],0.285778755561799,trans
Chapter IX Diseases of the circulatory system,I9_CHD,F13B,Coagulation factor XIII B chain,Inverse variance weighted,10,1.04 [0.97-1.11],0.289395344669625,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.02 [0.98-1.06],0.289548882128839,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MMP7,Matrilysin,Wald ratio,1,0.92 [0.8-1.07],0.292568047089742,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.08 [0.94-1.23],0.293545658382408,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.97 [0.9-1.03],0.297374377985507,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.1 [0.92-1.31],0.297765758194162,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.94 [0.84-1.06],0.298404875804998,trans
Chapter IX Diseases of the circulatory system,I9_CHD,OCLN,Occludin,Inverse variance weighted,2,1.13 [0.9-1.41],0.299419576698501,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD83,CD83 antigen,Inverse variance weighted,14,0.94 [0.85-1.05],0.300973325938503,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.01 [0.99-1.03],0.303644576722339,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.07 [0.94-1.22],0.304887320545132,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.96 [0.89-1.04],0.309405246497985,trans
Chapter IX Diseases of the circulatory system,I9_CHD,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.11 [0.91-1.34],0.310560072977212,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.84 [0.6-1.18],0.314097995972005,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.09 [0.92-1.28],0.321224664186096,trans
Chapter IX Diseases of the circulatory system,I9_CHD,OSM,Oncostatin-M,Inverse variance weighted,6,1.05 [0.95-1.16],0.323975380275026,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.09 [0.92-1.28],0.32409613144363,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.95 [0.86-1.05],0.324930167327994,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.04 [0.96-1.13],0.327321920633237,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HMOX1,Heme oxygenase 1,Inverse variance weighted,20,1.04 [0.96-1.12],0.33033047855513,trans
Chapter IX Diseases of the circulatory system,I9_CHD,XG,Glycoprotein Xg,Inverse variance weighted,2,0.88 [0.67-1.15],0.330841910560548,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.88 [0.67-1.15],0.335642392134422,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,1.05 [0.95-1.16],0.336489509409391,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GDF2,Growth/differentiation factor 2,Inverse variance weighted,31,0.97 [0.91-1.03],0.341282376048377,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.98 [0.95-1.02],0.341954856206478,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RETN,Resistin,Inverse variance weighted,19,0.96 [0.88-1.05],0.345517447872999,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.91 [0.74-1.11],0.346179108454404,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL13RA1,Interleukin-13 receptor subunit alpha-1,Inverse variance weighted,3,0.96 [0.88-1.05],0.350769339585728,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PI3,Elafin,Inverse variance weighted,18,1.02 [0.98-1.07],0.351230315363328,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.96 [0.88-1.04],0.354519252199161,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CNTN5,Contactin-5,Inverse variance weighted,22,1.03 [0.97-1.08],0.355425464268292,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.13 [0.87-1.45],0.356112582785021,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SDC1,Syndecan-1,Inverse variance weighted,12,1.06 [0.93-1.2],0.35893223487976,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.04 [0.95-1.14],0.359691808111898,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.02 [0.98-1.05],0.36129635842507,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KLK4,Kallikrein-4,Inverse variance weighted,5,0.83 [0.56-1.23],0.363358778550473,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.05 [0.95-1.16],0.365183902776219,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MUC13,Mucin-13,Inverse variance weighted,3,0.89 [0.68-1.15],0.365301588326344,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CREG1,Protein CREG1,Inverse variance weighted,20,0.97 [0.92-1.03],0.366034299366839,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.98 [0.93-1.03],0.367633069658598,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.93 [0.79-1.09],0.36841102975922,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.2 [0.8-1.81],0.368759770645637,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.93 [0.78-1.1],0.37408813517564,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SPON1,Spondin-1,Inverse variance weighted,4,1.08 [0.91-1.27],0.374955747748969,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.96 [0.89-1.04],0.379141550948212,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.88 [0.66-1.17],0.382718309437399,trans
Chapter IX Diseases of the circulatory system,I9_CHD,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.94 [0.81-1.09],0.384414867827783,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.95 [0.86-1.06],0.384748832973312,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.1 [0.88-1.37],0.387370695992831,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RSPO3,R-spondin-3,Inverse variance weighted,5,0.84 [0.57-1.24],0.38800273472311,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.07 [0.92-1.24],0.390398113058658,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.18 [0.81-1.72],0.393910881621535,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,25,1.04 [0.95-1.14],0.394803555466152,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.95 [0.85-1.07],0.399644097088003,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.04 [0.95-1.13],0.400952172567018,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.96 [0.86-1.06],0.401316316972522,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD209,CD209 antigen,Inverse variance weighted,34,1.02 [0.98-1.06],0.40186164807846,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.05 [0.94-1.17],0.401989574350975,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CFD,Complement factor D,Wald ratio,1,0.87 [0.62-1.21],0.403266843213347,trans
Chapter IX Diseases of the circulatory system,I9_CHD,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,0.98 [0.95-1.02],0.408594155007327,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.03 [0.95-1.12],0.411363435171292,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,0.99 [0.96-1.02],0.416885118005322,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.05 [0.93-1.19],0.417434346618538,trans
Chapter IX Diseases of the circulatory system,I9_CHD,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.94 [0.82-1.08],0.420313447272295,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GUCA2A,Guanylin,Inverse variance weighted,7,1.05 [0.93-1.17],0.42663743209508,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.46 [0.57-3.78],0.431168537975042,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.97 [0.89-1.05],0.431944748816574,trans
Chapter IX Diseases of the circulatory system,I9_CHD,F7,Coagulation factor VII,Inverse variance weighted,10,1.05 [0.93-1.19],0.435363863478562,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.07 [0.9-1.27],0.436472594017258,trans
Chapter IX Diseases of the circulatory system,I9_CHD,UPB1,Beta-ureidopropionase,Wald ratio,1,0.69 [0.27-1.78],0.441537292806283,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.11 [0.85-1.46],0.442674435069675,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.05 [0.92-1.2],0.445398914947481,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.93 [0.76-1.13],0.446100322465902,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CHGB,Secretogranin-1,Inverse variance weighted,7,1.04 [0.94-1.14],0.447187376116935,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.19 [0.76-1.86],0.44820810675063,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.09 [0.88-1.34],0.449801221571194,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,38,1.02 [0.97-1.06],0.452641879893946,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.97 [0.88-1.06],0.453611391859572,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.91 [0.72-1.16],0.458311110114049,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.92 [0.75-1.14],0.461759105443865,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.07 [0.89-1.3],0.466292014044175,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.92 [0.73-1.16],0.466327307319356,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.13 [0.81-1.59],0.471715265441466,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.98 [0.94-1.03],0.473849115096313,trans
Chapter IX Diseases of the circulatory system,I9_CHD,S100G,Protein S100-G,Inverse variance weighted,4,0.94 [0.81-1.11],0.4747543133379,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,35,1.01 [0.98-1.05],0.475615745652306,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.14 [0.8-1.61],0.477577612304,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.5 [0.48-4.68],0.482321215922346,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SPP1,Osteopontin,Inverse variance weighted,13,0.95 [0.82-1.1],0.484547766107678,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.12 [0.81-1.57],0.490261241904442,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.01 [0.97-1.06],0.49081514401105,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.98 [0.93-1.04],0.492679825616617,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.04 [0.93-1.17],0.495086351086363,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.96 [0.84-1.09],0.502506477568027,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.09 [0.85-1.38],0.504026988759916,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.04 [0.93-1.16],0.50503223881601,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.02 [0.95-1.1],0.50790095689907,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.07 [0.87-1.33],0.510857280950858,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.1 [0.82-1.49],0.515194757104657,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PALM2,Paralemmin-2,Inverse variance weighted,9,1.02 [0.96-1.09],0.518595858030587,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NECTIN2,Nectin-2,Inverse variance weighted,3,1.11 [0.81-1.51],0.524009862457827,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.11 [0.8-1.54],0.526598361242926,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.92 [0.7-1.2],0.527739979223126,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.01 [0.98-1.05],0.528039093303505,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.06 [0.89-1.26],0.532507922473766,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD27,CD27 antigen,Inverse variance weighted,9,1.06 [0.88-1.28],0.532681201190877,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.94 [0.78-1.14],0.534738255627599,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.91 [0.68-1.23],0.539052523445177,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.15 [0.73-1.83],0.542834837268226,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.04 [0.91-1.19],0.544463931507523,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.9 [0.64-1.27],0.545625248109611,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LGALS3,Galectin-3,Inverse variance weighted,15,0.97 [0.87-1.08],0.546437707868951,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.96 [0.86-1.09],0.549261313742519,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LEP,Leptin,Inverse variance weighted,4,1.19 [0.68-2.08],0.550609525178363,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.93 [0.73-1.19],0.557037783813217,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.92 [0.71-1.2],0.557817790624856,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.04 [0.92-1.16],0.560896331494667,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,0.83 [0.44-1.56],0.561772348906558,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,1.07 [0.84-1.37],0.564299851992574,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SOST,Sclerostin,Inverse variance weighted,31,1.02 [0.95-1.1],0.56460499778062,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.14 [0.72-1.8],0.566450179354031,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.02 [0.96-1.08],0.56681587032514,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.11 [0.78-1.59],0.568381196273446,trans
Chapter IX Diseases of the circulatory system,I9_CHD,APOE,Apolipoprotein E,Inverse variance weighted,6,1.05 [0.89-1.23],0.571294175670751,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.09 [0.81-1.46],0.576866321826824,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.11 [0.77-1.59],0.578618264229309,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.96 [0.85-1.1],0.579793070015132,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LMNB2,Lamin-B2,Inverse variance weighted,8,1.05 [0.89-1.23],0.582268456697844,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LPA,Apolipoprotein(a),Inverse variance weighted,2,1.14 [0.71-1.83],0.582416812990398,trans
Chapter IX Diseases of the circulatory system,I9_CHD,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.07 [0.85-1.35],0.583237840376747,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.07 [0.84-1.36],0.586798751668248,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,0.99 [0.97-1.02],0.596549173079382,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.02 [0.95-1.1],0.600537059325222,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.08 [0.81-1.43],0.602522638132827,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.06 [0.85-1.33],0.607570762042048,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,1.1 [0.77-1.55],0.608158683472381,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.07 [0.82-1.4],0.611169755818256,trans
Chapter IX Diseases of the circulatory system,I9_CHD,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.04 [0.9-1.19],0.612770624162108,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.97 [0.84-1.11],0.617524012380641,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.06 [0.85-1.31],0.619418379073073,trans
Chapter IX Diseases of the circulatory system,I9_CHD,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,1.02 [0.94-1.11],0.622810231224462,trans
Chapter IX Diseases of the circulatory system,I9_CHD,AGRN,Agrin,Inverse variance weighted,14,1.04 [0.9-1.19],0.62688595878441,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.87 [0.49-1.54],0.626933165802215,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CTSB,Cathepsin B,Inverse variance weighted,28,0.98 [0.92-1.05],0.628695394186951,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PSAP,Prosaposin,Inverse variance weighted,13,0.99 [0.94-1.04],0.629707400265284,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.94-1.04],0.630443970828458,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.96 [0.82-1.13],0.634028737851447,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.06 [0.84-1.33],0.641300096697249,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.94 [0.7-1.24],0.644004313939435,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.01 [0.96-1.07],0.649623442646659,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.97 [0.85-1.11],0.653524438852312,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.02 [0.94-1.11],0.659133442726617,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SCG3,Secretogranin-3,Inverse variance weighted,16,1.02 [0.94-1.11],0.661067112502085,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.97 [0.85-1.11],0.66124015239467,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.01 [0.97-1.04],0.661782567951682,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.02 [0.93-1.11],0.662807485567024,trans
Chapter IX Diseases of the circulatory system,I9_CHD,INHBC,Inhibin beta C chain,Inverse variance weighted,12,1.03 [0.91-1.16],0.666028630482085,trans
Chapter IX Diseases of the circulatory system,I9_CHD,BSG,Basigin,Inverse variance weighted,6,1.06 [0.82-1.37],0.668875123463537,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.05 [0.84-1.3],0.669100228191343,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.98 [0.87-1.09],0.671028679628793,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.02 [0.92-1.14],0.671350873025798,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.05 [0.84-1.31],0.672059948415731,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCN5,CCN family member 5,Inverse variance weighted,12,1.01 [0.96-1.07],0.67341173762445,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,0.99 [0.93-1.05],0.675888214518835,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCN3,CCN family member 3,Inverse variance weighted,17,1.02 [0.92-1.13],0.676716112207591,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.01 [0.96-1.07],0.677356309995885,trans
Chapter IX Diseases of the circulatory system,I9_CHD,XCL1,Lymphotactin,Inverse variance weighted,15,0.97 [0.83-1.13],0.682515542008382,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.09 [0.73-1.61],0.683913655349029,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PGF,Placenta growth factor,Inverse variance weighted,5,1.03 [0.9-1.16],0.691683298164177,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NFASC,Neurofascin,Inverse variance weighted,6,0.95 [0.71-1.25],0.694393878924902,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,0.99 [0.93-1.05],0.694631327486224,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.07 [0.77-1.49],0.697122007243977,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.08 [0.73-1.59],0.698687937356393,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.98 [0.87-1.1],0.702600984137871,trans
Chapter IX Diseases of the circulatory system,I9_CHD,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.01 [0.95-1.07],0.70545154673171,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.01 [0.95-1.08],0.708643657706935,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.02 [0.93-1.11],0.710881903746955,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.97 [0.82-1.14],0.722089432072954,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CALCA,Calcitonin,Inverse variance weighted,13,0.97 [0.8-1.17],0.73164780208265,trans
Chapter IX Diseases of the circulatory system,I9_CHD,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.03 [0.89-1.18],0.735363173751104,trans
Chapter IX Diseases of the circulatory system,I9_CHD,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.05 [0.8-1.37],0.738982909319721,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.02 [0.92-1.12],0.739322697163859,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.01 [0.96-1.06],0.740339215883163,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.07 [0.73-1.56],0.742076131020442,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.05 [0.8-1.37],0.742925577183271,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.99 [0.93-1.05],0.743071162160412,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CFC1,Cryptic protein,Inverse variance weighted,11,1.02 [0.89-1.18],0.744380735963311,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.98 [0.86-1.11],0.749172064579561,trans
Chapter IX Diseases of the circulatory system,I9_CHD,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.96 [0.77-1.2],0.75077806796434,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.03 [0.86-1.22],0.750798512173084,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,0.95 [0.7-1.3],0.754723156439986,trans
Chapter IX Diseases of the circulatory system,I9_CHD,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,0.98 [0.88-1.1],0.755102620722609,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.02 [0.89-1.18],0.757599362120362,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SELE,E-selectin,Inverse variance weighted,20,0.99 [0.92-1.06],0.759224128295136,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.05 [0.77-1.43],0.762230753896194,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CST3,Cystatin-C,Inverse variance weighted,3,0.94 [0.61-1.44],0.764963254747297,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.01 [0.96-1.05],0.767589823355055,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.02 [0.89-1.17],0.767757172041811,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.06 [0.71-1.58],0.767882736385243,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.03 [0.84-1.26],0.771611376727087,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.03 [0.83-1.29],0.777720029913476,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.99 [0.89-1.09],0.77828255109827,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.02 [0.9-1.15],0.783777491464016,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ACAN,Aggrecan core protein,Inverse variance weighted,30,1.01 [0.93-1.1],0.784525377643843,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,0.96 [0.74-1.26],0.788792705356643,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.02 [0.89-1.16],0.79194550657154,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.97 [0.74-1.25],0.79412147409608,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,1.08 [0.62-1.88],0.794166942612887,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.99 [0.9-1.08],0.794883065205882,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CDH2,Cadherin-2,Inverse variance weighted,21,0.98 [0.85-1.13],0.798173371568353,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.96 [0.72-1.29],0.79965984792411,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KLK11,Kallikrein-11,Inverse variance weighted,13,1.01 [0.91-1.13],0.800942171385713,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.99 [0.91-1.08],0.805146229751236,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.03 [0.84-1.25],0.809178298075499,trans
Chapter IX Diseases of the circulatory system,I9_CHD,COLEC12,Collectin-12,Inverse variance weighted,3,1.05 [0.73-1.5],0.809326534916508,trans
Chapter IX Diseases of the circulatory system,I9_CHD,AMBP,Protein AMBP,Inverse variance weighted,5,0.98 [0.81-1.18],0.811969972978928,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ROBO2,Roundabout homolog 2,Inverse variance weighted,6,0.98 [0.84-1.15],0.812933841661367,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.08 [0.58-1.98],0.815844620663864,trans
Chapter IX Diseases of the circulatory system,I9_CHD,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,37,0.99 [0.94-1.05],0.821876786130829,trans
Chapter IX Diseases of the circulatory system,I9_CHD,THPO,Thrombopoietin,Inverse variance weighted,12,0.99 [0.92-1.07],0.822401538523116,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.98-1.02],0.823322677465323,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PTN,Pleiotrophin,Inverse variance weighted,3,0.97 [0.71-1.31],0.826313701237806,trans
Chapter IX Diseases of the circulatory system,I9_CHD,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.01 [0.96-1.06],0.830054871920686,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.99 [0.93-1.06],0.830244945056959,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.01 [0.93-1.09],0.833201933663065,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.98 [0.81-1.18],0.835002601531081,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.98 [0.8-1.2],0.837549288483202,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.01 [0.93-1.09],0.840260098261681,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.03 [0.74-1.45],0.840808724086505,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CTSS,Cathepsin S,Inverse variance weighted,7,1.03 [0.78-1.35],0.844186678788644,trans
Chapter IX Diseases of the circulatory system,I9_CHD,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.97 [0.7-1.34],0.84428810369843,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.98 [0.76-1.25],0.844313213038659,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.99 [0.87-1.12],0.844445146237352,trans
Chapter IX Diseases of the circulatory system,I9_CHD,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,0.99 [0.93-1.06],0.846985514427529,trans
Chapter IX Diseases of the circulatory system,I9_CHD,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.96 [0.67-1.4],0.850994292568239,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.98 [0.83-1.17],0.851668066818405,trans
Chapter IX Diseases of the circulatory system,I9_CHD,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.02 [0.81-1.3],0.851943072705523,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.01 [0.88-1.16],0.855955028464744,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CFH,Complement factor H,Inverse variance weighted,7,0.99 [0.89-1.1],0.858329327304137,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MVK,Mevalonate kinase,Wald ratio,1,0.93 [0.41-2.11],0.865000231899453,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.99 [0.88-1.11],0.866156885482041,trans
Chapter IX Diseases of the circulatory system,I9_CHD,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.99 [0.93-1.06],0.867775190733434,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.01 [0.93-1.08],0.868349888810605,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1 [0.96-1.05],0.871056023509955,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,0.99 [0.86-1.13],0.871343071208783,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PRSS2,Trypsin-2,Inverse variance weighted,17,1.01 [0.94-1.07],0.872297316442311,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.01 [0.92-1.11],0.877364763822635,trans
Chapter IX Diseases of the circulatory system,I9_CHD,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,1.01 [0.93-1.09],0.879819700573337,trans
Chapter IX Diseases of the circulatory system,I9_CHD,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,0.99 [0.83-1.17],0.885240617414491,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.01 [0.9-1.12],0.885757029228611,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.01 [0.85-1.2],0.897150011659892,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PGA4,Pepsin A-4,Inverse variance weighted,7,0.99 [0.84-1.17],0.897750244631924,trans
Chapter IX Diseases of the circulatory system,I9_CHD,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.02 [0.74-1.42],0.897917541049565,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.01 [0.86-1.19],0.905852491381137,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.99 [0.91-1.09],0.916178642485768,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NRP2,Neuropilin-2,Inverse variance weighted,14,1.01 [0.89-1.14],0.91751590138172,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1 [0.96-1.04],0.922606326401034,trans
Chapter IX Diseases of the circulatory system,I9_CHD,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.99 [0.73-1.33],0.936954033102435,trans
Chapter IX Diseases of the circulatory system,I9_CHD,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.01 [0.7-1.47],0.941403298285107,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.03 [0.49-2.16],0.944168133633907,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PRSS8,Prostasin,Inverse variance weighted,14,1 [0.88-1.12],0.956372263574433,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PENK,Proenkephalin-A,Inverse variance weighted,15,1 [0.91-1.1],0.958110682870246,trans
Chapter IX Diseases of the circulatory system,I9_CHD,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1 [0.89-1.13],0.970736547416428,trans
Chapter IX Diseases of the circulatory system,I9_CHD,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1 [0.92-1.09],0.970747999645418,trans
Chapter IX Diseases of the circulatory system,I9_CHD,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1 [0.9-1.12],0.971902391446118,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1 [0.83-1.21],0.973559939145609,trans
Chapter IX Diseases of the circulatory system,I9_CHD,POF1B,Protein POF1B,Inverse variance weighted,4,1 [0.78-1.27],0.975057541558332,trans
Chapter IX Diseases of the circulatory system,I9_CHD,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1 [0.91-1.1],0.976221886915606,trans
Chapter IX Diseases of the circulatory system,I9_CHD,SCG2,Secretogranin-2,Inverse variance weighted,2,1 [0.82-1.23],0.978189823268526,trans
Chapter IX Diseases of the circulatory system,I9_CHD,UMOD,Uromodulin,Inverse variance weighted,34,1 [0.93-1.08],0.980068274296194,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EFNA4,Ephrin-A4,Inverse variance weighted,2,1 [0.73-1.35],0.980197242741996,trans
Chapter IX Diseases of the circulatory system,I9_CHD,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1 [0.92-1.09],0.981046254417702,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1 [0.86-1.17],0.981492593074637,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CLEC3B,Tetranectin,Inverse variance weighted,2,0.99 [0.58-1.69],0.983068195584778,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,1 [0.68-1.47],0.987651768596701,trans
Chapter IX Diseases of the circulatory system,I9_CHD,EPO,Erythropoietin,Inverse variance weighted,11,1 [0.9-1.11],0.988247289905831,trans
Chapter IX Diseases of the circulatory system,I9_CHD,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1 [0.97-1.03],0.988862854280343,trans
Chapter IX Diseases of the circulatory system,I9_CHD,STC1,Stanniocalcin-1,Inverse variance weighted,9,1 [0.79-1.27],0.989636785113674,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GAL,Galanin peptides,Inverse variance weighted,49,1 [0.92-1.09],0.992593997392021,trans
Chapter IX Diseases of the circulatory system,I9_CHD,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1 [0.95-1.05],0.99566337184354,trans
Chapter IX Diseases of the circulatory system,I9_CHD,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1 [0.9-1.11],0.996244670164291,trans
